Study Comparing Two Different Tablet Formulations Of Bosutinib Under Fed Conditions
Completed · Phase 1
Conditions studied: Healthy
In brief
Study comparing 2 formulations of bosutinib in healthy subjects.
Key facts
- Study ID
- NCT01080365
- Run by
- Wyeth is now a wholly owned subsidiary of Pfizer
- People needed
- 31
- Starts
- 2010-02-01
- Expected to finish
- 2010-03-01
- Last updated by the study team
- 2010-09-06
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Men or women of nonchildbearing potential age 18 to 50 years
You may not qualify if…
- Any clinically significant medical condition
Where it is running
- Pfizer Investigational Site — Tacoma, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.